Solid Biosciences (SLDB) Enterprise Value (2017 - 2024)
Historic Enterprise Value for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to -$171.1 million.
- Solid Biosciences' Enterprise Value fell 1975.94% to -$171.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$171.1 million, marking a year-over-year decrease of 1975.94%. This contributed to the annual value of -$123.6 million for FY2023, which is 4214.91% up from last year.
- As of Q3 2024, Solid Biosciences' Enterprise Value stood at -$171.1 million, which was down 1975.94% from -$190.3 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Enterprise Value registered a high of -$24.8 million during Q3 2020, and its lowest value of -$268.5 million during Q1 2021.
- Over the past 5 years, Solid Biosciences' median Enterprise Value value was -$162.9 million (recorded in 2022), while the average stood at -$154.7 million.
- As far as peak fluctuations go, Solid Biosciences' Enterprise Value skyrocketed by 7653.2% in 2020, and later plummeted by 40104.88% in 2021.
- Over the past 5 years, Solid Biosciences' Enterprise Value (Quarter) stood at -$154.7 million in 2020, then tumbled by 34.27% to -$207.8 million in 2021, then decreased by 2.86% to -$213.7 million in 2022, then surged by 42.15% to -$123.6 million in 2023, then plummeted by 38.4% to -$171.1 million in 2024.
- Its Enterprise Value stands at -$171.1 million for Q3 2024, versus -$190.3 million for Q2 2024 and -$206.1 million for Q1 2024.